Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin.
Hanna RM, Streja E, Kalantar-Zadeh K.
Adv Ther. 2021 Jan;38(1):52-75. doi: 10.1007/s12325-020-01524-6. Epub 2020 Oct 29.
Erythropoiesis-stimulating agent hyporesponsiveness.
Johnson DW, Pollock CA, Macdougall IC.
Nephrology (Carlton). 2007 Aug;12(4):321-30. doi: 10.1111/j.1440-1797.2007.00810.x.
Anaemia in CKD-treatment standard.
Macdougall IC.
Nephrol Dial Transplant. 2024 Apr 26;39(5):770-777. doi: 10.1093/ndt/gfad250.
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
Goodkin DA, Zhao J, Cases A, Nangaku M, Karaboyas A.
Am J Nephrol. 2022;53(5):333-342. doi: 10.1159/000523947. Epub 2022 Apr 22.
Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients.
Nangaku M, Mimura I, Yamaguchi J, Higashijima Y, Wada T, Tanaka T.
J Ren Nutr. 2015 Mar;25(2):160-3. doi: 10.1053/j.jrn.2014.10.011. Epub 2014 Dec 30.
Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis.
Lee HY, Suh SW, Hwang JH, Shin J.
Front Nutr. 2022 Dec 2;9:1044895. doi: 10.3389/fnut.2022.1044895. eCollection 2022.
How I treat anemia in pregnancy: iron, cobalamin, and folate.
Achebe MM, Gafter-Gvili A.
Blood. 2017 Feb 23;129(8):940-949. doi: 10.1182/blood-2016-08-672246. Epub 2016 Dec 29.
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
Macdougall IC, Meadowcroft AM, Blackorby A, Cizman B, Cobitz AR, Godoy S, Jha V, Johansen KL, McMahon G, Obrador GT, Wong MG, Singh AK.
Am J Nephrol. 2023;54(1-2):1-13. doi: 10.1159/000528696. Epub 2023 Feb 7.
Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients.
Ogawa T, Nitta K.
Contrib Nephrol. 2015;185:76-86. doi: 10.1159/000380972. Epub 2015 May 19.
Resistance to Erythropoiesis-Stimulating Agents in Pre-Dialysis and Post-Dialysis Mortality in Japanese Incident Hemodialysis Patients.
Hayashi T, Joki N, Tanaka Y, Iwasaki M, Kubo S, Matsukane A, Takahashi Y, Imamura Y, Hirahata K, Hase H.
Blood Purif. 2019;47 Suppl 2(Suppl 1):31-37. doi: 10.1159/000496634. Epub 2019 Apr 3.
